These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27272796)

  • 41. Pretreatment dietary patterns, weight status, and head and neck squamous cell carcinoma prognosis.
    Arthur AE; Peterson KE; Rozek LS; Taylor JM; Light E; Chepeha DB; Hébert JR; Terrell JE; Wolf GT; Duffy SA;
    Am J Clin Nutr; 2013 Feb; 97(2):360-8. PubMed ID: 23269814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical analysis of 71 cases of multiple primary cancers in head and neck squamous carcinomas].
    Zhou YQ; Li XM; Gao CM; Zhao QL; Li GS; Cheng JM; Shang YD
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Apr; 39(4):232-6. PubMed ID: 15283285
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Salvage surgery after local recurrence in patients with head and neck carcinoma treated with chemoradiotherapy or bioradiotherapy.
    León X; Agüero A; López M; García J; Farré N; López-Pousa A; Quer M
    Auris Nasus Larynx; 2015 Apr; 42(2):145-9. PubMed ID: 25459494
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Standardized uptake value and resection margin involvement predict outcomes in pN0 head and neck cancer.
    Joo YH; Yoo IeR; Cho KJ; Park JO; Nam IC; Kim MS
    Otolaryngol Head Neck Surg; 2013 Nov; 149(5):721-6. PubMed ID: 23921497
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary tumor volume is an important predictor of clinical outcomes among patients with locally advanced squamous cell cancer of the head and neck treated with definitive chemoradiotherapy.
    Strongin A; Yovino S; Taylor R; Wolf J; Cullen K; Zimrin A; Strome S; Regine W; Suntharalingam M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1823-30. PubMed ID: 21549516
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognosis: a variable parameter: dynamic prognostic modeling in head and neck squamous cell carcinoma.
    van der Schroeff MP; Steyerberg EW; Wieringa MH; Langeveld TP; Molenaar J; Baatenburg de Jong RJ
    Head Neck; 2012 Jan; 34(1):34-41. PubMed ID: 21322079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial.
    Caponigro F; Di Gennaro E; Ionna F; Longo F; Aversa C; Pavone E; Maglione MG; Di Marzo M; Muto P; Cavalcanti E; Petrillo A; Sandomenico F; Maiolino P; D'Aniello R; Botti G; De Cecio R; Losito NS; Scala S; Trotta A; Zotti AI; Bruzzese F; Daponte A; Calogero E; Montano M; Pontone M; De Feo G; Perri F; Budillon A
    BMC Cancer; 2016 Nov; 16(1):918. PubMed ID: 27884140
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
    Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of coronavirus disease 2019 on recurrences and follow up of head and neck squamous cell carcinoma.
    Kytö E; Haapio E; Kinnunen I; Irjala H
    J Laryngol Otol; 2021 Apr; 135(4):344-347. PubMed ID: 33752762
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Salvage surgery in recurrent head and neck squamous cell carcinoma: Oncologic outcome and predictors of disease free survival.
    Hamoir M; Holvoet E; Ambroise J; Lengelé B; Schmitz S
    Oral Oncol; 2017 Apr; 67():1-9. PubMed ID: 28351561
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interim FDG PET/CT for predicting the outcome in patients with head and neck cancer.
    Chen SW; Hsieh TC; Yen KY; Yang SN; Wang YC; Chien CR; Liang JA; Kao CH
    Laryngoscope; 2014 Dec; 124(12):2732-8. PubMed ID: 25042474
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selection of Ideal Candidates for Surgical Salvage of Head and Neck Squamous Cell Carcinoma: Effect of the Charlson-Age Comorbidity Index and Oncologic Characteristics on 1-Year Survival and Hospital Course.
    Kim J; Kim S; Albergotti WG; Choi PA; Kaplan DJ; Abberbock S; Johnson JT; Gildener-Leapman N
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1059-65. PubMed ID: 26447790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
    Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
    Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK; Sessions DG; Lenox J
    Laryngoscope; 2005 Apr; 115(4):629-39. PubMed ID: 15805872
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MR imaging of recurrent head and neck tumours following flap reconstructive surgery.
    Tomura N; Watanabe O; Hirano Y; Kato K; Takahashi S; Watarai J
    Clin Radiol; 2002 Feb; 57(2):109-13. PubMed ID: 11977942
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recurrent Malignancy in Osteoradionecrosis Specimen.
    Marwan H; Green JM; Tursun R; Marx RE
    J Oral Maxillofac Surg; 2016 Nov; 74(11):2312-2316. PubMed ID: 27235177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The value of routine follow-up in patients treated for carcinoma of the vulva.
    Oonk MH; de Hullu JA; Hollema H; Mourits MJ; Pras E; Wymenga AN; van der Zee AG
    Cancer; 2003 Dec; 98(12):2624-9. PubMed ID: 14669281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.